Evolocumab Biosimilar - Research Grade
Product Specifications
Background
Evolocumab biosimilar is a human monoclonal immunoglobulin G2 (IgG2) directed against human proprotein convertase subtilisin kexin 9 (PCSK9). Evolocumab biosimilarhas an approximate molecular weight (MW) of 144 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells.
Specifications
Detects human PCSK9. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Evolocumab.
Product Name Alternative
Proprotein convertase subtilisin/kexin type 9, NARC-1, PC9
UniProt
Q8NBP7
Host
Humanized
Species Reactivity
Human
Target
PCSK9
Isotype
IgG2
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
1.0 - 5.0 mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE and HPLC
Buffer
ICH3001-100mL ICH3002-100mL ICH3003-100mL
Shipping Conditions
Blue ice
Storage Conditions
Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Formulation
Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
Isotype Control
https://ichor.bio/product/bulk-human-igg2-isotype-control-ib2-ich2255/
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC226216L4V 200 µL
PDE4A (NM_001111308) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
QDD31016-01 250 mg
6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid hydrochloride
Sign In for Pricing
View Details QDD31016-02 2.5 g
6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid hydrochloride
Sign In for Pricing
View Details